BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 10395116)

  • 1. Regional drug information service.
    Schwarz UI; Stoelben S; Ebert U; Siepmann M; Krappweis J; Kirch W
    Int J Clin Pharmacol Ther; 1999 Jun; 37(6):263-8. PubMed ID: 10395116
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Drug information for patients--an update of long-term results: type of enquiries and patient characteristics.
    Huber M; Kullak-Ublick GA; Kirch W
    Pharmacoepidemiol Drug Saf; 2009 Feb; 18(2):111-9. PubMed ID: 19101916
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Twenty years' experience with drug information centers.
    Amerson AB; Wallingford DM
    Am J Hosp Pharm; 1983 Jul; 40(7):1172-8. PubMed ID: 6881155
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Drug information centers: future trends.
    Rosenberg JM
    Am J Hosp Pharm; 1983 Jul; 40(7):1213-5. PubMed ID: 6881162
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Short communication: pattern of adverse drug reaction related queries received by the drug information centre of a tertiary care teaching hospital.
    Jimmy B; Jose J; Rao PG
    Pak J Pharm Sci; 2007 Oct; 20(4):333-9. PubMed ID: 17604259
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Drug information centers: meeting future needs for drug information.
    Cardoni AA
    Am J Hosp Pharm; 1983 Jul; 40(7):1215-7. PubMed ID: 6881163
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Contribution of the regional drug information center towards drug safety.
    Palaian S; Mishra P; Shankar PR; Bista D; Purwar B
    JNMA J Nepal Med Assoc; 2006; 45(161):216-8. PubMed ID: 17160101
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacist-operated drug information centres in Singapore.
    Lim LY; Chui WK
    J Clin Pharm Ther; 1999 Feb; 24(1):33-42. PubMed ID: 10319905
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Medication Information Line for the Elderly. A consumer/health care professional-oriented drug information service.
    Grymonpré RE; Steele JW; Schultz BR
    CPJ; 1987 May; 120(5):324-6, 327-30. PubMed ID: 10282069
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quality assurance program for a drug information center.
    Park BA; Benderev KP
    Am J Hosp Pharm; 1985 Oct; 42(10):2180-4. PubMed ID: 4061459
    [TBL] [Abstract][Full Text] [Related]  

  • 11. External quality assurance committee for drug information services.
    Smith CJ; Sylvia LM
    Am J Hosp Pharm; 1990 Apr; 47(4):787-91. PubMed ID: 2321653
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effectiveness of drug information centers.
    Amerson AB
    Crit Rev Med Inform; 1986; 1(2):135-48. PubMed ID: 3333020
    [TBL] [Abstract][Full Text] [Related]  

  • 13. National audit of drug information centers.
    Dombrowski SR; Visconti JA
    Am J Hosp Pharm; 1985 Apr; 42(4):819-26. PubMed ID: 4014232
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Drug information centers-instruments for health care research?].
    Hach I; Meusel D; Maywald U; Kirch W
    Med Klin (Munich); 2005 Jul; 100(7):396-400. PubMed ID: 16010474
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Obstetric drug information service.
    Arulappu RG; Taylor DJ
    Am J Hosp Pharm; 1982 Sep; 39(9):1511-4. PubMed ID: 7137189
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The NCI All Ireland Cancer Conference.
    Johnston PG; Daly PA; Liu E
    Oncologist; 1999; 4(4):275-277. PubMed ID: 10545862
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Clinical pharmacological drug information. Well over one year's experience].
    Heisterberg J; Christophersen AB; Christensen HR; Sonne J
    Ugeskr Laeger; 1999 Jun; 161(26):4005-7. PubMed ID: 10402937
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Utilization of a community pharmacy-operated national drug information call center in Finland.
    Pohjanoksa-Mäntylä MK; Antila J; Eerikäinen S; Enäkoski M; Hannuksela O; Pietilä K; Airaksinen M
    Res Social Adm Pharm; 2008 Jun; 4(2):144-52. PubMed ID: 18555967
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Documenting the activity and effectiveness of a regional drug information center.
    Golightly LK; Davis AG; Budwitz WJ; Gelman CJ; Rathmann KL; Sutherland EW; Rumack BH
    Am J Hosp Pharm; 1988 Feb; 45(2):356-61. PubMed ID: 3364436
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anabolic ergogenic substance users in fitness-sports: a distinct group supported by the health care system.
    Striegel H; Simon P; Frisch S; Roecker K; Dietz K; Dickhuth HH; Ulrich R
    Drug Alcohol Depend; 2006 Jan; 81(1):11-9. PubMed ID: 16009506
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.